Solid Tumors and Hematologic Malignancy
6 clinical trials · Condition
◉ Watch Solid Tumors and Hematologic Malignancy
| Record | Firm | Date |
|---|---|---|
| An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies (NCT02712905) | Incyte Corporation | 2016-05-05 |
| A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients (NCT02492789) | Atridia Pty Ltd. | 2015-09-01 |
| An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies (NCT02431260) | Incyte Corporation | 2015-04-14 |
| Itacitinib in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations (NCT02355431) | Incyte Corporation | 2014-12-01 |
| A Dose-escalation Study in Subjects With Advanced Malignancies (NCT01195311) | Incyte Corporation | 2010-07-01 |
| Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors (NCT00820560) | Incyte Corporation | 2005-01-01 |
Track Solid Tumors and Hematologic Malignancy automatically
Every clearance here is in the API, with alerts when new ones post.